Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
liver disease
Pharma
FDA approves Corstasis' nasal spray as treatment for edema
The FDA has approved Corstasis Therapeutics’ nasal spray Enbumyst to relieve the edema associated with heart failure and kidney and liver disease.
Kevin Dunleavy
Sep 15, 2025 3:33pm
Gilead fashions new primary biliary cholangitis campaign
Sep 10, 2025 7:00am
Fierce Biotech
Zydus' phase 3 win tees up filing to challenge Gilead and Ipsen
Aug 29, 2025 10:59am
Madrigal's first-ever MASH drug beats sales projections again
May 2, 2025 11:00am
Ipsen touts early launch results for liver disease drug Iqirvo
Apr 17, 2025 8:47am
EU authorities revoke marketing nod for Advanz Pharma's Ocaliva
Dec 2, 2024 2:54pm
